These S&P500 stocks are gapping in today's session

ILLUMINA INC (ILMN)       206.005   -9.15 (-4.25%)


News Image
These S&P500 stocks are gapping in today's session2 months ago - Chartmill

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Gap down stocks

TickerChangeComment
EQT-4.0%EQT CORP's (NYSE:EQT) stock price decreased by 4.0% to $39.86 with a gap of 8.14%. In the last year the share price increased with 112.0%.
CCL-3.61%CARNIVAL CORP's (NYSE:CCL) stock price decreased by 3.61% to $9.61 with a gap of 8.16%. Shareholders saw the stock price going 26.2% lower is the past 6 months.
SNPS-3.54%SYNOPSYS INC's (NASDAQ:SNPS) stock price is declining with 3.54% to a price of $345.18 with a gap of 6.45%. Shareholders saw the stock price going 27.3% higher in the past month.
PYPL-3.46%PAYPAL HOLDINGS INC's (NASDAQ:PYPL) stock price is declining with 3.46% to a price of $75.81 with a gap of 6.68%. Shareholders saw the stock price going 57.3% lower is the past year.
APTV-3.46%APTIV PLC's (NYSE:APTV) stock price is declining with 3.46% to a price of $101.55 with a gap of 6.12%. Shareholders saw the stock price going 35.21% lower is the past year.
FTNT-3.45%FORTINET INC's (NASDAQ:FTNT) stock price is declining with 3.45% to a price of $53.47 with a gap of 4.66%.
ILMN-3.35%ILLUMINA INC's (NASDAQ:ILMN) shares fell 3.35% to $213.47 during Friday's session with a gap of 5.84%. Shareholders saw the stock price going 36.4% lower is the past year.
ANET-3.31%ARISTA NETWORKS INC's (NYSE:ANET) stock price is declining with 3.31% to a price of $135.15 with a gap of 5.39%. In the last 6 months the stock gained 35.49%.
WFC-3.19%WELLS FARGO & CO's (NYSE:WFC) shares fell 3.19% to $45.38 with a gap of 6.43%. Yesterday the company had a press release: Wells Fargo Named a Global Best in Service Winner by Euromoney Magazine.
ADI-3.15%ANALOG DEVICES INC's (NASDAQ:ADI) stock price decreased by 3.15% to $166.07 with a gap of 4.6%. The stock is trading 21.41% higher than a month ago.

For the full top loser list go to our gap down stocks screener.

Back

ILMN Links

ILMN News

News Image2 hours ago - Seeking AlphaIllumina downgraded to hold at Argus on poor near-term outlook (NASDAQ:ILMN)

Argus has downgraded Illumina (ILMN) to hold from buy citing falling margins and worsening outlook.

News Image7 days ago - Seeking AlphaNIH outlays fall, US govt healthcare grants grow but Biopharma financings fall Y/Y

Outlays from the National Institutes of Health ((NIH)) for December 2022 decreased ~4% Y/Y (-35% versus November 2022), according to report from Baird Equity Research.December 2022...

News Image12 days ago - Market News VideoFriday Sector Leaders: Healthcare, ServicesNews Image12 days ago - Investor's Business DailyStock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review

Sharp Tesla price cuts and some notable earnings were in focus.

News Image13 days ago - Market News VideoThursday Sector Laggards: Healthcare, UtilitiesNews Image13 days ago - Market News VideoNasdaq 100 Movers: ZS, CTSHNews Image13 days ago - Market News VideoS&P 500 Movers: CRL, CTSHNews Image14 days ago - Seeking AlphaIllumina facing huge fine from EU over closing GRAIL deal without antitrust approval

Illumina may have to pay a fine of 10% of its annual turnover to the EU as a penalty for closing its 2021 acquisition of GRAIL without receiving antitrust clearance,, Reuters reported.

News Image14 days ago - Yahoo FinanceExclusive-Illumina to face EU fine of 10% of turnover over Grail deal -sources

U.S. life sciences company Illumina is likely to face a fine of 10% of its global annual turnover, the maximum penalty, for closing its takeover of Grail without waiting for EU antitrust approval, people familiar with the matter said. Last month Illumina defended its case before senior European Commission and national competition officials at a closed hearing but failed to convince them, the people said. Illumina, which last year set aside $453 million for a potential EU fine, said it would appeal against any fine.

News Image14 days ago - ReutersExclusive: Illumina to face EU fine of 10% of turnover over Grail deal -sources

U.S. life sciences company Illumina is likely to face a fine of 10% of its global annual turnover, the maximum penalty, for closing its takeover of Grail without waiting for EU antitrust approval, people familiar with the matter said.

News Image15 days ago - Seeking AlphaWhy did Illumina stock drop today? Weak 2023 outlook (NASDAQ:ILMN)

Illumina (ILMN) closed down 6% on Tuesday after its 2023 outlook came in below expectations.

News Image15 days ago - PRLogUniversal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech

CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key distributors in Europe, to offer full-service solutions for Long Read Sequencing Applications using UST TELL-Seq Linked Read technology.TATAA Biocenter was founded in 2001 and is a leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industries in Europe and to the Cell and Gene Therapy industry in the United States.UST's TELL-Seq technology, a transposase-based patent-pending linked-read library technology, enables short read 2nd generation NGS platforms, such as Illumina sequencers, to produce super long-range sequencing results (averaging linked-read molecule length greater than 40kb, up to and exceeding 200kb). A sequencing-ready library can be prepared in a PCR tube in ~3 hours with a simple workflow and basic lab equipment, which is simple, fast, and cost-effective. A unique feature of UST TELL-Seq is that it only requires ultra-low DNA input, 3-5ng for the human genome and 0.1-0.5ng for microbial genomes and target sequencing panels.Dr. Aaron U. Levy, GM & Chief Commercial Officer of UST, who recently visited the TATAA Biocenter facility in Gothenburg, stated that he was impressed with the laboratory's setup, corporate culture, professionalism, and up-to-code superb sequencing services. Levy added that "TELL-Seq library technology is compatible with the range of Illumina sequencing platforms from benchtop like MiniSeq™ up to high-throughput NovaSeq™ 6000. The collaboration between UST and TATAA, based on the growing need for long-read results with very accurate short-read Illumina sequencers is speeding up the adoption of UST's super long-range TELL-Seq NGS library products among Illumina users in the US and all over the world."With UST TELL-Seq library preparation kits and an Illumina sequencer, one can do de novo sequencing of microbial, animal, plant, and insect genomes, metagenomics, human genome phasing, and structural variation detection.Mikael Kubista, the founder and CEO of TATAA Biocenter, stated, "The innovative TELL-Seq Linked-Read Technology for long-read sequencing is a most welcome complement to our service offerings. Our customers and sponsors will now gain additional advantages over their competitors through our broad range of qualified molecular services."ABOUT TATAA BIOCENTERTATAA Biocenter is a leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industry in Europe and to the Cell and Gene Therapy industry in the United States. With ISO 17025 accreditation and Good Laboratory and Clinical Practices(GLP/GCP) ready facility TATAA is perfectly positioned to support the pharmaceutical industry with biomarker profiling, including genomics, transcriptomics, and proteomics with traditional qPCR, dPCR, and NGS methods, as well as proprietary methods.ABOUT UNIVERSAL SEQUENCING TECHNOLOGY CORPORATIONUniversal Sequencing Technology Corporation (UST), a Boston and San Diego-based NGS biotechnology company, was established by a group of NGS veterans. UST is dedicated to developing the most advanced DNA sequencing technologies and has filed more than 20 provisional patent applications covering linked read NGS library preparation, single-cell sequencing, and groundbreaking 3rd generation DNA sequencing technologies. UST is poised to lead the next wave of DNA sequencing innovations.www.universalsequencing.com

Follow us for more